Explore more publications!

Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

Press releases published on March 5, 2026

Crypto News: Pepeto Confirms Binance Listing Soon as XRP Price Prediction Targets $10 and Whales Move In
MediWound Files Annual Report on Form 20-F
Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026
Outlook Therapeutics Provides Update Following Type A Meeting with FDA Regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg)
$Mambo Launches Global “Year of the Horse” Fan Campaign Celebrating Viral Uma Musume Meme
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
Amneal to Participate in Upcoming Investor Conference
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
Weebit Nano’s ReRAM Selected for Korean National Compute-in-Memory Program
Crypto News: Pepeto Raises $7.58 Million and Introduces Staking Rewards Program to Support Long-Term Ecosystem Participation
Dubai Property Exhibition Hosts 20 Leading Agencies as 'DPS Talks' Platform Launches
Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions
Quanta Therapeutics Presents Preclinical Data Establishing that Direct Multi-KRAS Inhibitors Retain Strong Activity Against Resistance Mechanisms Acquired from Treatment with pan-RAS Tri-Complex Inhibitors
Crypto News: Pepeto Exchange Bridge Approaches Final Testing as Bitcoin Price Prediction From Arthur Hayes Targets $750,000
Duke Robotics Announces 25-for-1 Reverse Stock Split
ADI Foundation and Chainlink Announce Official Partnership to Accelerate Stablecoin and Tokenization Strategy Across the Middle East, Africa, and Asia
B2PRIME Secures SCB Licences, Advancing Multi-Asset Trading
Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
Alarum to Release Fourth Quarter & Full Year 2025 Results on March 19, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions